Free Trial

Edwards Lifesciences (EW) Competitors

$88.03
+0.57 (+0.65%)
(As of 01:27 PM ET)

EW vs. STE, ISRG, ZBH, ALGN, MRNA, DXCM, COR, ALC, HUM, and IDXX

Should you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include STERIS (STE), Intuitive Surgical (ISRG), Zimmer Biomet (ZBH), Align Technology (ALGN), Moderna (MRNA), DexCom (DXCM), Cencora (COR), Alcon (ALC), Humana (HUM), and IDEXX Laboratories (IDXX). These companies are all part of the "medical" sector.

Edwards Lifesciences vs.

STERIS (NYSE:STE) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.

94.7% of STERIS shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 1.0% of STERIS shares are held by company insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

STERIS currently has a consensus price target of $241.60, suggesting a potential upside of 6.27%. Edwards Lifesciences has a consensus price target of $94.31, suggesting a potential upside of 6.91%. Given STERIS's stronger consensus rating and higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STERIS
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Edwards Lifesciences
1 Sell rating(s)
5 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.63

Edwards Lifesciences received 988 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 71.84% of users gave Edwards Lifesciences an outperform vote while only 58.51% of users gave STERIS an outperform vote.

CompanyUnderperformOutperform
STERISOutperform Votes
323
58.51%
Underperform Votes
229
41.49%
Edwards LifesciencesOutperform Votes
1311
71.84%
Underperform Votes
514
28.16%

Edwards Lifesciences has higher revenue and earnings than STERIS. Edwards Lifesciences is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STERIS$5.14B4.39$378.24M$3.8259.82
Edwards Lifesciences$6.00B8.83$1.40B$2.3237.94

Edwards Lifesciences has a net margin of 23.01% compared to Edwards Lifesciences' net margin of 6.95%. STERIS's return on equity of 22.86% beat Edwards Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
STERIS6.95% 13.73% 7.73%
Edwards Lifesciences 23.01%22.86%16.52%

In the previous week, Edwards Lifesciences had 11 more articles in the media than STERIS. MarketBeat recorded 19 mentions for Edwards Lifesciences and 8 mentions for STERIS. Edwards Lifesciences' average media sentiment score of 0.99 beat STERIS's score of 0.86 indicating that STERIS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STERIS
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Edwards Lifesciences
11 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STERIS has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Summary

Edwards Lifesciences beats STERIS on 14 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EW vs. The Competition

MetricEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$53.05B$9.07B$5.12B$17.77B
Dividend YieldN/A1.25%2.81%3.49%
P/E Ratio37.9414.98138.4723.12
Price / Sales8.8350.602,447.3210.32
Price / Cash32.6522.3835.9519.57
Price / Book7.384.365.435.92
Net Income$1.40B$182.64M$104.35M$976.39M
7 Day Performance-1.25%-1.78%-1.41%-1.68%
1 Month Performance-0.67%0.56%2.68%3.03%
1 Year Performance5.00%-10.61%3.39%22.72%

Edwards Lifesciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STE
STERIS
4.3189 of 5 stars
$230.60
-0.9%
$241.60
+4.8%
+12.3%$23.00B$5.14B60.3717,100
ISRG
Intuitive Surgical
4.476 of 5 stars
$402.11
+0.5%
$396.17
-1.5%
+32.2%$142.63B$7.12B72.5813,676
ZBH
Zimmer Biomet
4.7778 of 5 stars
$118.97
-0.1%
$134.40
+13.0%
-11.1%$24.48B$7.39B25.7518,000Analyst Upgrade
Analyst Revision
ALGN
Align Technology
4.9818 of 5 stars
$264.02
-1.3%
$353.00
+33.7%
-10.7%$19.88B$3.92B43.5021,610Positive News
MRNA
Moderna
3.3914 of 5 stars
$143.69
+1.9%
$126.46
-12.0%
+19.1%$55.07B$6.85B-9.175,600
DXCM
DexCom
4.9378 of 5 stars
$130.84
+0.1%
$141.67
+8.3%
+8.6%$52.03B$3.62B84.419,600Positive News
COR
Cencora
4.0932 of 5 stars
$217.10
-1.8%
$233.90
+7.7%
+28.4%$44.08B$638.56M23.7546,000Analyst Revision
News Coverage
ALC
Alcon
2.8192 of 5 stars
$88.64
+0.6%
$94.71
+6.8%
+14.1%$43.44B$9.56B42.0125,000
HUM
Humana
4.9013 of 5 stars
$355.59
+0.1%
$426.39
+19.9%
-30.5%$42.85B$106.37B22.1467,600
IDXX
IDEXX Laboratories
4.3272 of 5 stars
$518.44
-2.2%
$580.38
+11.9%
+11.9%$42.82B$3.66B50.1911,000Analyst Upgrade

Related Companies and Tools

This page (NYSE:EW) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners